AARTI DRUGS LTD. - 524348 - Clarification On Announcement Dated Sept 20, 2024 .On USFDA Inspection At API Manufacturing Facility Of The Company

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348 | ISIN: INE767A01016 | Industry: Pharmaceuticals
| Mid-range Performer

482.2000 12.25 (2.61%)

NSE Sep 29, 2025 15:31 PM

54.55% Gain from 52W Low

Volume: 154.8K

Aarti Drugs Ltd.

25 Sep 2024

482.20

2.61%

Company Update

AARTI DRUGS LTD. - 524348 - Clarification On Announcement Dated Sept 20, 2024 .On USFDA Inspection …

BSE India

Clarification on announcement dated Sept 20, 2024 on USFDA inspection at API manufacturing facility of the Company

More from Aarti Drugs Ltd.

Recommended

IPO frenzy continues: 23 companies to list; 21 new issues hit the market this week

| 29 Sep 2025, 04:41PM

Market closes flat, E2E Networks approves Rs 1,000 crore QIP

Trendlyne Marketwatch | 29 Sep 2025, 04:08PM

Earnings Call Transcript - Q1FY21 for Aarti Drugs